• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

抗结核治疗药物监测实践：国际调查。

Practices of therapeutic drug monitoring in tuberculosis: an international survey.

机构信息

Dept of Clinical Pharmacy and Pharmacology, Rijksuniversiteit Groningen, University Medical Centrum Groningen, Groningen, The Netherlands

University of Groningen, University Medical Centrum Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.

出版信息

Eur Respir J. 2022 Apr 14;59(4). doi: 10.1183/13993003.02787-2021. Print 2022 Apr.

DOI:10.1183/13993003.02787-2021
PMID:35086830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9030066/
Abstract

https://bit.ly/34PFSfd

摘要

[文献链接]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2784/9030066/0f640dad7425/ERJ-02787-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2784/9030066/0f640dad7425/ERJ-02787-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2784/9030066/0f640dad7425/ERJ-02787-2021.01.jpg

相似文献

1
Practices of therapeutic drug monitoring in tuberculosis: an international survey.抗结核治疗药物监测实践：国际调查。
Eur Respir J. 2022 Apr 14;59(4). doi: 10.1183/13993003.02787-2021. Print 2022 Apr.
2
Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?结核病中的固定剂量复方制剂与治疗药物监测：是友还是敌？
Eur Respir J. 2016 Oct;48(4):1230-1233. doi: 10.1183/13993003.00833-2016. Epub 2016 Sep 1.
3
Treatment of tuberculosis.结核病的治疗。
J Indian Med Assoc. 1996 Sep;94(9):349-50.
4
Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities.活动性肺结核患者的治疗药物监测实践：机会评估
Eur Respir J. 2021 Jan 28;57(1). doi: 10.1183/13993003.02349-2020. Print 2021 Jan.
5
Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care.结合数字依从性技术与治疗药物监测以实现个性化结核病护理。
Eur Respir J. 2022 Dec 8;60(6). doi: 10.1183/13993003.01690-2022. Print 2022 Dec.
6
[Strengthen the study of anti-tuberculosis drug-induced liver injury in China].加强我国抗结核药物性肝损伤的研究
Zhonghua Jie He He Hu Xi Za Zhi. 2019 May 12;42(5):323-325. doi: 10.3760/cma.j.issn.1001-0939.2019.05.002.
7
Tuberculin test after therapy.治疗后的结核菌素试验。
Indian Pediatr. 1996 Nov;33(11):984.
8
Treatment of tuberculosis.结核病的治疗。
MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77.
9
Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives.抗结核化疗中的治疗药物监测：临床视角
Clin Chim Acta. 2001 Nov;313(1-2):31-6. doi: 10.1016/s0009-8981(01)00646-5.
10
Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment?编者按：死还是活：活力染色能否预测结核病治疗反应？
Clin Infect Dis. 2015 Apr 15;60(8):1196-8. doi: 10.1093/cid/ciu1156. Epub 2014 Dec 23.

引用本文的文献

1
State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case.利福平实际浓度监测的技术现状及其在资源有限环境中的实施情况：以坦桑尼亚为例
JAC Antimicrob Resist. 2024 Nov 14;6(6):dlae182. doi: 10.1093/jacamr/dlae182. eCollection 2024 Dec.
2
Therapeutic drug monitoring in tuberculosis.结核病治疗药物监测。
Eur J Clin Pharmacol. 2024 Nov;80(11):1659-1684. doi: 10.1007/s00228-024-03749-8. Epub 2024 Sep 6.
3
Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB.

本文引用的文献

1
Saliva-based linezolid monitoring on a mobile UV spectrophotometer.基于唾液的利奈唑胺监测，采用移动紫外分光光度计。
J Antimicrob Chemother. 2021 Jun 18;76(7):1786-1792. doi: 10.1093/jac/dkab075.
2
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes.测量成人和儿童头发中的结核药物水平，以监测药物暴露和结果。
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):52-60. doi: 10.5588/ijtld.20.0574.
3
Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities.
异烟肼尿液分光光度法预测成人结核病患者的血清药代动力学
IJTLD Open. 2024 Feb;1(2):90-95. doi: 10.5588/ijtldopen.23.0361.
4
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations.抗结核药物浓度国际室间质量控制计划十年结果。
J Antimicrob Chemother. 2024 Jun 3;79(6):1346-1352. doi: 10.1093/jac/dkae105.
5
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?唾液治疗药物监测在抗菌治疗中的应用：可行还是徒劳？
Clin Pharmacokinet. 2024 Mar;63(3):269-278. doi: 10.1007/s40262-024-01346-7. Epub 2024 Feb 1.
6
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians.我们如何治疗药物敏感型肺结核：临床医生实用指南
Antibiotics (Basel). 2023 Dec 14;12(12):1733. doi: 10.3390/antibiotics12121733.
7
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.一种用于耐多药结核病治疗中相关一线和二线抗生素治疗药物监测的单次运行高效液相色谱-质谱多重检测法
Pharmaceutics. 2023 Oct 27;15(11):2543. doi: 10.3390/pharmaceutics15112543.
8
TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine.结核病治疗药物监测——罗马尼亚和乌克兰的机遇分析。
Int J Tuberc Lung Dis. 2023 Nov 1;27(11):816-821. doi: 10.5588/ijtld.22.0667.
9
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.贝达喹啉、普托马尼德和利奈唑胺在美国的应用：使用新型全口服治疗方案治疗利福平耐药或利福平不耐受结核病的经验。
Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312.
10
Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review.临床环境中治疗结核病的治疗药物监测和剂量调整的替代方法：系统评价。
Clin Pharmacokinet. 2023 Mar;62(3):375-398. doi: 10.1007/s40262-023-01220-y. Epub 2023 Mar 4.
活动性肺结核患者的治疗药物监测实践：机会评估
Eur Respir J. 2021 Jan 28;57(1). doi: 10.1183/13993003.02349-2020. Print 2021 Jan.
4
Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.尿液比色法和手机读数测定利福平浓度用于结核病治疗的个体化给药。
J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):104-111. doi: 10.1093/jpids/piaa024.
5
Challenging the management of drug-resistant tuberculosis.挑战耐药结核病的管理。
Lancet. 2020 Mar 7;395(10226):783. doi: 10.1016/S0140-6736(20)30049-0.
6
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.耐药结核病治疗。美国胸科学会/美国疾病控制与预防中心/欧洲呼吸学会/美国感染病学会临床实践指南。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.
7
Therapeutic Drug Monitoring: The Need for Practical Guidance.治疗药物监测：对实用指南的需求。
Clin Infect Dis. 2019 Mar 5;68(6):1065-1066. doi: 10.1093/cid/ciy787.
8
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会官方临床实践指南：药物敏感型肺结核的治疗
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.
9
Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics.将治疗药物监测纳入世界卫生组织结核病诊断体系。
Eur Respir J. 2016 Jun;47(6):1867-9. doi: 10.1183/13993003.00040-2016. Epub 2016 Mar 17.
10
End TB with precision treatment!通过精准治疗终结结核病！
Eur Respir J. 2016 Feb;47(2):680-2. doi: 10.1183/13993003.01285-2015.